Editors: Atta-ur-Rahman, Mohammad Iqbal Choudhary

Frontiers in Drug Design and Discovery

Volume 5

Personal Book: US $44 Special Offer (PDF + Printed Copy): US $161
Printed Copy: US $139
Library Book: US $176
ISSN: 1574-0889
eISSN: 2212-1064 (Online)
ISBN: 978-1-60805-527-2
eISBN: 978-1-60805-203-5 (Online)
Year of Publication: 2010
DOI: 10.2174/97816080520351100501

Introduction

Frontiers in Drug Design and Discovery is a book series devoted to publishing the latest and the most important advances in drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, and structure-activity relationships. The book series should prove to be of interest to all the pharmaceutical scientists involved in research in drug design and discovery. Each volume is devoted to the major advances in drug design and discovery.

The book series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.

The book series is available in print, online and CD editions.

Indexed in

EMBASE, Scopus, Genamics JournalSeek

Indexed in: Scopus, EMBASE, EBSCO, Ulrich's Periodicals Directory.

Contributors

Editor(s):
Atta-ur-Rahman FRS
Honorary Life Fellow
Kings College
University of Cambridge
UK


Mohammad Iqbal Choudhary
University of Karachi
Pakistan




Contributor(s):
P.Y. Chang
Massachusetts Eye Research and Surgery Institution
Cambridge
MA
USA


D.M. Christmas
Psychopharmacology Unit
University of Bristol
Bristol , BS1 3NY
UK
/
School of Psychiatry and Clinical Neurosciences (M521)
University of Western Australia
Perth
Australia


F. Duan
Center for Statistical Sciences
Brown University
Providence
RI , 02912
USA


G.P. Giuliari
Massachusetts Eye Research and Surgery Institution
Cambridge
MA
USA


S.D. Hood
School of Psychiatry and Clinical Neurosciences (M521)
University of Western Australia
Perth
Australia


T. Isogai
Graduate School of Pharmaceutical Sciences, The University of Tokyo
Tokyo
Japan


M. Jeppesen
Section of Neurobiology, Biomedicine, Department of Health Science and Technology
Aalborg University
Aalborg University
Denmark


M. Kluska
Institute of Chemistry
University of Podlasie
Siedlce
Poland


J.J.Z. Liao
Merck Research Laboratories
West Point
PA , 19486
USA


H. Maruta
NF CURE Japan
Melbourne, 3055
Australia


Y. Meng
Merck Research Laboratories
West Point
PA , 19486
USA


T. Moos
Section of Neurobiology, Biomedicine, Department of Health Science and Technology
Aalborg University
Denmark


G. Menon
School of Psychiatry and Clinical Neurosciences (M521)
University of Western Australia
Perth
Australia


S.M. Messerli
Marine Biological Laboratory
Woods Hole, Mass.
USA


T. Puig
Institut d'Investigació Biomèdica de Girona (IdIBGi), Hospital Dr. Josep Trueta
Girona, E-17007
Spain
/
Bioquímica i Biologia Molecular, Facultat de Ciències i Medicina, Universitat de Girona, Campus Montilivi s/n,
Girona, E-17007
Spain


J. Relat
Departament de Bioquímica i Biologia Molecular, Facultat de Farmàcia
Universitat de Barcelona, Av. Diagonal 643
Barcelona, E-08028
Spain


A. Tanaka
Department of Pharmacy
Hyogo University of Health Sciences
Japan


Q. Zhao
Merck Research Laboratories
West Point
PA , 19486
USA